Core Viewpoint - The internationalization of traditional Chinese medicine (TCM) has become a national strategy, with policies supporting its global expansion, creating a golden opportunity for the industry [1] Group 1: Successful Entry into Singapore - The first overseas market for the company, Singapore, has shown exceptional commercial results, validating the feasibility of its internationalization model [2] - By July 2025, revenue from Singapore stores increased by 119% year-on-year, demonstrating rapid growth in overseas performance [2] - The high customer retention rate indicates that the company's operational system is well-received in the overseas market, providing a replicable model for future global expansion [2] Group 2: Strategic Expansion Plans - Following the successful validation in Singapore, the company has outlined a strategic path focusing on "technology + products + store expansion" for international growth [3] - The company plans to focus on the Hong Kong market in 2025 and aims to expand its Singapore clinics to over 20 by the end of 2026 [3] Group 3: Technological Innovations - The company is addressing the shortage of TCM practitioners overseas by launching AI technology that encapsulates the clinical experience of top TCM experts [4] - The AI system has achieved over 86% consistency with expert simulations, enhancing the diagnostic capabilities of overseas TCM practitioners [4] - The establishment of a TCM heritage studio in Singapore aims to train and send skilled practitioners abroad, further improving service quality [4] Group 4: Product Development and Market Penetration - The successful certification and launch of the hair care product in Singapore marks a significant milestone in the company's product internationalization efforts [5] - The company has accumulated over 22 million patient records and 18 million structured medical records, enhancing the precision and safety of its product development [5] - The certification of the hair care product provides a reusable template for future product launches overseas [6] Group 5: Store Expansion Strategies - The company plans to adopt a mixed strategy for store expansion, combining self-built flagship stores, strategic partnerships, and acquisitions to enhance market penetration [6] - Self-built flagship stores will establish brand recognition and serve as a model for regional expansion [6] - Collaborations with local medical institutions will leverage existing customer bases, while acquisitions of quality clinics will create a differentiated competitive advantage [6] Group 6: Future Outlook - The company is moving towards becoming a global brand in TCM, with a closed-loop strategy of service expansion, cost reduction through technology, and profitability through product offerings [6] - The ongoing expansion into the Hong Kong market and the establishment of 20 clinics in Singapore are expected to solidify the company's position in the global TCM sector [6]

Core Viewpoint - The conference on high-quality development of traditional Chinese medicine (TCM) highlighted the strategic layout of Guoshengtang in promoting the internationalization of TCM through "management empowerment + AI technology + products" to establish itself as the leading TCM health brand for the global Chinese community [1] Group 1: Management Strategy - Guoshengtang has initiated its internationalization journey by acquiring Singapore's Baozhongtang, achieving a revenue increase of 119% year-on-year by July 2025 [1] - The company plans to expand to 30 clinics in Singapore by the end of 2026, leveraging its successful operational model from China [1] - The company employs a multi-faceted strategy for overseas expansion, including self-built flagship stores, strategic partnerships, and acquisitions of local medical institutions [2] Group 2: AI Technology - Guoshengtang launched 10 AI avatars of renowned TCM doctors to address the shortage of quality TCM talent overseas, enhancing the internationalization of TCM [2][3] - The AI avatars have achieved over 86% consistency with expert simulations, improving diagnostic accuracy and medication rationality [4] - The AI technology aids in alleviating the scarcity of quality TCM resources and enhances the efficiency of top experts, while also supporting the training of younger doctors [4] Group 3: Product Development - Guoshengtang has made significant advancements in the development of traditional Chinese medicine (TCM) products, with its first proprietary TCM product receiving certification in Singapore [5][6] - The company has initiated a project to create an integrated platform for clinical evaluation of TCM, leveraging AI and big data to enhance clinical research and innovation [6] - Guoshengtang aims to strengthen its product development efforts, focusing on innovative TCM formulations and ensuring the legacy of renowned TCM practitioners through its products [7]